SynthesisFrontiers in pharmacology2025

Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis.

Wenjun Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.